Neoplasms Metastasis Completed Phase 1 Trials for Imexon (DB05003)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00327223Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated MalignancyTreatment